Gene · 3438
Papers2,276
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,276
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New approach methodologies to assess wanted and unwanted drugs-induced immunostimulation. | Curr Res Toxicol | 2025 | 40027547 | PubTator, text mining | PubMed |
| Avenciguat: a novel soluble guanylate cyclase activator that affects multiple cell types to inhibit IFN-1 signalling and fibrosis. | Rheumatology (Oxford) | 2025 | 39985455 | PubTator, text mining | PubMed |
| Pharmacodynamics of the S1P1 receptor modulator cenerimod in a phase 2b randomised clinical trial in patients with moderate to severe SLE. | Ann Rheum Dis | 2025 | 39919901 | PubTator, text mining | PubMed |
| Characterizing substructure via mixture modeling in large-scale genetic summary statistics. | Am J Hum Genet | 2025 | 39824191 | PubTator, text mining | PubMed |
| From Viral Infection to Skin Affliction: Unveiling Mechanisms of Cutaneous Manifestations in COVID-19 and Post-COVID Conditions. | J Invest Dermatol | 2025 | 39665720 | PubTator, text mining | PubMed |
| Downregulation of type I interferon signalling pathway by urate in primary human PBMCs. | Immunology | 2025 | 39354748 | PubTator, text mining | PubMed |
| Current status and research progress of oncolytic virus. | Pharm Sci Adv | 2024 | 41550155 | PubTator, text mining | PubMed |
| High throughput screen identifies lysosomal acid phosphatase 2 (ACP2) to regulate IFN-1 responses to potentiate oncolytic VSV∆51 activity. | Sci Rep | 2024 | 39550388 | PubTator, text mining | PubMed |
| Immunomodulatory properties of extracellular vesicles isolated from bone marrow of patients with neuroblastoma: role of PD-L1 and HLA-G. | Front Immunol | 2024 | 39512342 | PubTator, text mining | PubMed |
| Extracellular vesicles from human-induced pluripotent stem cell-derived neural stem cells alleviate proinflammatory cascades within disease-associated microglia in Alzheimer's disease. | J Extracell Vesicles | 2024 | 39499013 | PubTator, text mining | PubMed |
| The cGAS-STING mediated crosstalk between innate immunity and autophagy in leishmaniasis using mathematical modeling: Uncovering new therapeutic avenues. | Arch Biochem Biophys | 2024 | 39486567 | PubTator, text mining | PubMed |
| The curious case of type I interferon signaling in cancer. | Biochim Biophys Acta Rev Cancer | 2024 | 39477031 | PubTator, text mining | PubMed |
| Expression of key immune genes in polarized porcine monocyte-derived macrophage subsets. | Vet Immunol Immunopathol | 2024 | 39427365 | PubTator, text mining | PubMed |
| CNS disease associated with enhanced type I interferon signalling. | Lancet Neurol | 2024 | 39424561 | PubTator, text mining | PubMed |
| A Novel Treatment for Skin Manifestations in Dermatomyositis: A Case Report. | Cureus | 2024 | 39262502 | PubTator, text mining | PubMed |
| Genome-wide characterization of extrachromosomal circular DNA in SLE and functional analysis reveal their association with apoptosis. | Transl Res | 2024 | 39173965 | PubTator, text mining | PubMed |
| Grouper TIM-1 promotes nodavirus infection by inhibiting immune and inflammation response. | Fish Shellfish Immunol | 2024 | 39117128 | PubTator, text mining | PubMed |
| Single-cell peripheral immunoprofiling of lewy body and Parkinson's disease in a multi-site cohort. | Mol Neurodegener | 2024 | 39090623 | PubTator, text mining | PubMed |
| Dendritic Cell Plasticity, Radiation, and Newton's Third Law. | Clin Cancer Res | 2024 | 39087954 | PubTator, text mining | PubMed |
| Impact of Genomic Mutation on Melanoma Immune Microenvironment and IFN-1 Pathway-Driven Therapeutic Responses. | Cancers (Basel) | 2024 | 39061208 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3438/papers?page=4